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Both the Massachusetts Department of Environmental Protection (MADEP) and the Total Petroleum Hydrocarbon Criteria
Working Group (TPHCWG) developed fraction-based approaches for assessing human health risks posed by total petroleum
hydrocarbon (TPH) mixtures in the environment. Both organizations deﬁned TPH fractions based on their expected
environmental fate and by analytical chemical methods. They derived toxicity values for selected compounds within each fraction
and used these as surrogates to assess hazard or risk of exposure to the whole fractions. Membership in a TPH fraction is generally
deﬁned by the number of carbon atoms in a compound and by a compound’s equivalent carbon (EC) number index, which can
predictitsenvironmentalfate.Here,wesystematicallyandobjectivelyre-evaluatetheassignmentofTPHtospeciﬁcfractionsusing
comparative molecular ﬁeld analysis and hierarchical clustering. The approach is transparent and reproducible, reducing inherent
reliance on judgment when toxicity information is limited. Our evaluation of membership in these fractions is highly consistent
(∼80% on average across various fractions) with the empirical approach of MADEP and TPHCWG. Furthermore, the results
support the general methodology of mixture risk assessment to assess both cancer and noncancer risk values after the application
of fractionation.
1.Introduction
Contamination of the environment by petroleum products
including crude oil, lubricating oils, and a wide variety
of fuels is widespread. Typically, these petroleum pro-
ducts are complex mixtures containing hundreds to
thousands of diﬀerent hydrocarbon compounds, inclu-
ding aliphatic compounds (e.g., straight-chain, branched-
chain, and cyclic alkanes and alkenes) as well as aromatic
compounds (e.g., benzene and alkyl benzenes, poly-
cyclic aromatic hydrocarbons). Once released into the
environment, the composition of a petroleum hydrocarbon
mixture can change due to weathering (http://facstaﬀ.gpc
.edu/∼pgore/geology/geo101/weather.htm). During chemical
weathering, components of petroleum mixtures can degrade
and partition, such that the more soluble or volatile com-
pounds can be readily transported to other environmen-
tal media and locations, while the relatively nonmobile
and recalcitrant components (i.e., the weathered products)
remain near the point of release. Thus, the actual petroleum
hydrocarbon mixtures to which a population might be
exposed will vary with the petroleum product released,
environmental conditions, elapsed time following release,
and exposure medium.2 Journal of Toxicology
Table 1: MADEP toxicity values for TPH fractions [3].
Hydrocarbon fraction Oral (mg/kg/day) Inhalation (mg/m3)
Aliphatic
No.1: C5–C8 0.04 0.2
No.2: C9–C18 0.1 0.2
No.3: C19–C32 2.0 NV
a
Aromatic
No.1: C6–C8 SC
b SC
b
No.2: C9–C18 0.03c 0.05
No.3: C19–C32 0.03c NV
a
aNV: not volatile. bSC: used single chemical values (fraction includes
benzene, toluene, xylene, and ethyl benzene). cMADEP grouped the entire
range of aromatics from C9–C32 into a single fraction for oral noncancer
toxicity.
Assessment of human health risks associated with
petroleum-hydrocarbon-contaminated sites routinely begins
with an analysis of “total petroleum hydrocarbons” (TPHs).
TPHs are loosely deﬁned hydrocarbon mixtures. While the
components included in a mixture of TPHs depend on
the method of analysis and chemical nature of the TPH
contaminating material (e.g., jet fuels, gasoline, etc.), TPHs
typically represent the total mass of hydrocarbons without
identifying speciﬁc individual compounds. As TPHs is not
a consistent entity, the assessment of health eﬀects and
development of toxicity criteria such as reference doses
(RfDs)andcancerslopefactorsforsuchcomplexmixturesas
a whole are problematic (the RfD is an estimate of the dose
of daily exposure to a substance (with uncertainty spanning
perhaps an order of magnitude) for a human population
(including sensitive subgroups) that is likely to be without an
appreciable risk of deleterious eﬀects during a lifetime [1]).
As previously mentioned, both the Massachusetts
Department of Environmental Protection (MADEP) and
the Total Petroleum Hydrocarbons Criteria Working Group
(TPHsCWG) recommended a “fraction-based approach” for
assessing human health risks associated with TPH exposures
[2–8]. Both MADEP and TPHCWG divide the aliphatic
TPHs into three aliphatic fractions designated as aliph1–3
(Table 1). MADEP grouped the entire range of aromatics
from C9–C32 into a single fraction for the assessment
of oral noncancer toxicity and divided the fraction into
C9–C18 and C19–C32 fractions for the assessment of
inhalationnoncancertoxicity.Incontrast,TPHCWGdivided
the aromatic compounds into three individual aromatic
fractionsdesignatedasarom1–3.Followingmeasurementsto
determine the concentrations of the six fractions present at a
given site, human exposure to the individual fractions can be
estimated (Figure 1).
The noncancer health risk associated with each fraction
is then predicted based on the dose-response function of
a fraction-speciﬁc surrogate chemical(s). The underlying
a s s u m p t i o ni st h a te a c hm e m b e ro faf r a c t i o ni st o x i c o -
logically similar and shares a common mode of action
(MOA). USA EPA [9] deﬁnes “similar components” as
single chemicals that cause the same biologic activity or are
expected to cause the same type of biologic activity based on
chemical structure. These components also may be expected
to have comparable kinetic characteristics and toxicity. A
Hazard Index based on an assumption of dose addition is
then calculated to assess potential noncancer health risks
using both chronic and subchronic surrogate toxicity values
[9].
The cancer health risks associated with each fraction
can be estimated assuming either response addition for all
fractions but arom3 or dose addition for a subset of TPHs
in the arom3 fraction. For individual TPHs that have cancer
slope factors, the products of the TPH exposures and the
cancer slope factors are summed to estimate cancer risks
posedbythosecompoundsunderanassumptionofresponse
addition. For groups of carcinogenic TPHs assumed to act
throughacommontoxicmodeofaction,therelativepotency
factor approach is used. This approach requires both the
existence of toxicological dose-response data for at least
one component of the mixture, (i.e., the index chemical),
and scientiﬁc judgment that the toxicity of the other
individual compounds in the mixture are toxicologically
similar [9]. Using this approach, some polycyclic aromatic
hydrocarbons assigned to the arom3 fraction are assumed to
be dose-additive. These hydrocarbons have been assigned a
r e l a t i v ep o t e n c yf a c t o r .T h er e l a t i v ep o t e n c yf a c t o r sf o re a c h
compoundarecombinedwiththecompound-speciﬁc-intake
estimates to calculate an index chemical equivalent dose.
These equivalent doses are summed, and the total equivalent
dose is compared to a cancer slope factor for the index
chemical (i.e., benzo[a]pyrene); cancer risk for the fraction
is estimated based on this comparison [10].
As discussed by Teuschler [11], this approach to risk
assessment of TPHs “illustrates a ﬂexible method for
characterizing TPH exposures that reﬂects diﬀerences in
chemical composition across various sites and provides a
reasonable method for calculating potential health risks.” We
summarized the conceptual basis of the MADEP/TPHCWG
approach in Figure 1 principally based on the natural
and logical course of chemical extraction, separation,
and analysis. Such chemical analyses are intimately
associated with the physicochemical properties of the
component chemicals present in the TPH mixture (see
http://hhpprtv.ornl.gov/issue papers/ComplexMixturesof
AliphaticandAromaticHydrocarbons.pdf for full analysis).
For this chemical mixtures risk assessment approach, the
accurate assignment of the individual TPHs into speciﬁc
fractions is critical. Fraction or membership assignments
have been based on physicochemical properties (including
molecular structure such as aromatic versus aliphatic),
analytical data, prevalence in the environment (e.g., fate
and transport), and toxicological properties. The analytical
data are based on the number of carbon atoms (C) in the
compounds comprising the fraction or equivalent carbon
(EC) number index. Inaccurate assignments of TPHs into
fractions could lead to erroneous evaluations of the overall
noncancer and cancer risks. Table 1 summarizes noncancer
toxicity values for various TPH fractions derived by MADEP.
Because in silico molecular modeling or computational
modeling is often employed for analysis, interpretation, and
visualization of heterogeneous datasets from various sourcesJournal of Toxicology 3
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Figure 1: Approach to estimate TPH cancer risks and noncancer Hazard Indices using component and mixture fraction methods. Whole
mixture toxicity data are not available for the many, highly variable TPH mixtures of concern that are found at diﬀerent sites, and as a
result, both MADEP and TPHWG have proposed a fractional and subsequent surrogate/component-based approach for the risk assessment
of TPHs. This ﬁgure shows that following the measurement of TPHs in either soil or water, both MADEP and TPHWG recommend
that exposure estimates be developed for each fraction. Relying on surrogates for each fraction, Figure 1 shows that whole mixture risk
assessments can be done using data directly on the mixture of concern, on a suﬃciently similar mixture, on a mixture’s fractions, or on a
subset of its components.
(e.g., fractions) [12–15], we used an in silico approach
in this paper to systematically examine the assignment
of 111 selected TPH components into speciﬁc fractions.
These examinations are based on a molecular modeling
approach achieved through the application of comparative
molecular ﬁeld analysis (CoMFA2), which is based on
three-dimensional (3D) shape, electrostatic and hydrogen
bonding characteristics (assuming similar MOAs and molec-
ular targets) and then evaluated by hierarchical clustering.
CoMFA was speciﬁcally selected for capturing molecular
interactions between TPHs and their potential common
molecular targets. TPHs with common molecular targets
will likely be clustered together based on their CoMFA
descriptors, and these clustered TPHs are expected to be
assigned to a speciﬁc fraction (e.g., arom3 TPHs bind to
arylhydrocarbon receptor).Additional analysisbystructure-
activity relationship can also be utilized to evaluate mem-
bership consistency within a fraction. This approach was
applied to examine the underlying association of chemicals
within each fraction, thereby providing information relevant
to the assumed common toxicity of individual TPHs in each
fraction. We compared the assignments predicted using this
method to those developed by MADEP.
2.MaterialsandMethods
2.1. Selection of Individual TPHs. The selection of aliphatic
and aromatic TPHs was based on their abundance in
contaminated sites (e.g., composition and type of fuels)
and/or known qualitative signiﬁcant toxicity (e.g., endpoints
or critical eﬀects). Overall, 51 aliphatics and 60 aromatics
were chosen based on the available toxicity information as
the twomain datasets forsubsequent analysis and validation.
All selected aliphatic and aromatic TPHs are listed in Figures
2 and 3,r e s p e c t i v e l y .
2.2. Carbon Atoms (C) and Equivalent Carbon (EC). The EC
number is measured by comparing a compound’s retention
time in gas chromatography to that of various n-alkanes
[3, 8]. This index is equivalent to the retention time of the
compounds on a boiling-point gas chromatography (GC)
column (nonpolar capillary column) normalized to the n-
alkanes. For example, benzene, a C6 aromatic compound,
has an EC of 6.5 because its boiling-point and GC retention
time are approximately halfway between those of n-hexane
(C6, EC6) and n-heptane (C7, EC7). Physical and chemical
properties of hydrocarbons that are useful in predicting fate
and transport including vapor pressure, solubility, partition
coeﬃcient,andHenry’sLawconstantsarepredictablyrelated
to the EC and can be estimated using algorithms. Both
MADEP and TPHCWG have adopted this method for the
fractionation of TPHs.
2.3. In Silico Approach. Following the selection of the TPHs,
the analysis was conducted in three steps as follows: (1)
molecular modeling; (2) CoMFA analysis; (3) hierarchical
clustering analysis. Each step illustrates the characteristics4 Journal of Toxicology
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Figure 2: Hierarchical cluster analysis based on CoMFA for all aliphatic fractions. Surrogate chemicals proposed by MADEP [3]a r es h o w n
in bold and with asterisks.
and physicochemical properties of hydrocarbons within each
fraction.
Step 1. Molecular Modeling. Initial structures of the 111
TPHs were built using the Sketch Molecule module in Sybyl
8.0 (Tripos, Inc., St. Louis, MO, USA), and energy was
subsequentlyminimized toyieldastableconformationusing
the MMFF94 force ﬁeld and electrostatic charges [16]. The
51 aliphatics and 60 aromatics were processed and used
as two separate datasets for further analyses. Each dataset
was aligned using its common core structure (i.e., pentane
for aliphatics; and benzene for aromatics) prior to COMFA
analysis.
Step 2. Comparative Molecular Field Analysis (CoMFA).
Because most TPHs are postulated to have similar toxic
eﬀects or modes of action (e.g., toxicity, binding aﬃnity,
etc.), a CoMFA [17] was conducted based on the current
understanding of mixtures risk assessment [9, 10]. CoMFA
is a commonly used 3D quantitative structure-activity
relationship technique from which inferences can be made
about chemicals of interest based on data from known
active molecules. In general, to apply CoMFA to a group of
chemicals, all that is required for the analysis is the biological
activity (e.g., IC50) and the 3D structures of the molecules
assuming common molecular target(s). However, for this
paper, only the CoMFA descriptors were needed for further
hierarchical clustering; no biological activity data were used.
It was not our intent to develop quantitive structure-activity
relationship models. The 3D structures of the molecules
were constructed as described in Step 1. Brieﬂy, TPHs were
placed in a 3D grid with 2-˚ A spacing encompassing all of
the chemicals. At each grid point, both steric energy and
electrostatic energy were measured for each chemical by a
probe atom (sp3-hybridized carbon with +1 charge). All
steric and electrostatic energies were set to the default cutoﬀ
value of 30kcal/mol. All other parameters for CoMFA were
set to the default values in Sybyl 8.0. CoMFA values for each
compound were computed according to procedures in the
software manual (Sybyl 8.0, Tripos, Inc.).Journal of Toxicology 5
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Figure 3: Hierarchical cluster analysis based on CoMFA for all aromatic fractions. Proposed surrogate or component chemicals
are shown in bold and with asterisks. DBalP: Dibenzo[a,l]pyrene, BlAC: Benzo[l]aceanthrylene, IP: Indeno[1,2,3-c,d]pyrene, FA:
Fluoranthene, CPcdP: Clclopenta[c,d]pyrene, DBacA: Dibenzo[a,c]anthracene, BbcAC: 11H-Benzo[b,c]aceanthrylene, AA: Anthanthrene,
DBahA: Dibenzo[a,h]anthracene, BjAC: Benzo[j]aceanthrylene, BeAC: Benzo[e]aceanthrylene, BjF: Benzo[j]ﬂuoranthene, BaA:
Benzo[a]anthracene, N23eP: Naphtho[2,3-e]pyrene, BghiP: Benzo[g,h,i]perylene, Pyr: Pyrene, PH: Phenanthrene, AC: Anthracene,
DBaiP: Dibenzo[a,i]pyrene, DBahP: Dibenzo[a,h]pyrene, DBaeF: Dibenzo[a,e]ﬂuoranthene, DBaeP: Dibenzo[a,e]pyrene, BkF:
Benzo[k]ﬂuoranthene, BbF: Benzo[b]ﬂuoranthene, BaP: Benzo[a]pyrene, CH: Chrysene, 4H-CPdefC: 4H-Cyclopenta[d,e,f]chrysene.
Step 3. Hierarchical Clustering Analysis. Once the CoMFA
values of all selected TPHs were calculated, two heuristic
hierarchicalclusteringanalyseswereseparatelyconductedfor
aliphatic and aromatic groups (Figures 2 and 3). In general,
a hierarchical clustering analysis attempts to ﬁnd groupings
within a set of data. Based on the Euclidean distance between
points, a dendrogram showing the similarity/dissimilarity of
clusters at increasing levels of detail is displayed (Sybyl 8.0,
Tripos, Inc.). A hierarchical clustering analysis is performed
basedontheCoMFAresultsfromStep 2above.Initially,each
dot (i.e., chemical) on the rightmost column of the dataset of
TPHs can be considered as a basic cluster. The next nearest
pair of clusters is merged (indicating similarity in chemical
structureandpotentialbiologicalinteractions),thenthenext
nearest (to the left), and so forth until there is only one
cluster containing all the dots (chemicals) and branches.6 Journal of Toxicology
T h eo v e r a l lh i e r a r c h i c a lc l u s t e r i n gp r o c e s si sc a p t u r e da sa
dendrogram or inverted tree (note: for this paper, Figures 2
and 3 have been rotated 90◦ counterclockwise to facilitate
viewing). The rotated dendrogram should be read from
the right to the left, where each node at the rightmost
end represents a chemical, and the central branch at the
next merging point represents the entire dataset for one
cluster.Thelengthsofthehorizontallinesinthedendrogram
provide relative qualitative information about the linkage
distance (e.g., similarity) between various clusters. For
instance,clustersrepresentedbylongunbranchedstrandsare
strongly separated from other clusters (Figures 2 and 3).
The main property used to determine the distances on
which clustering operates is CoMFA descriptors. Once the
CoMFA column (an array of 3D descriptors) is generated,
the linkage method for hierarchical clustering is Complete
as recommended by the software manual (Sybyl 8.0, Tripos,
Inc.). In general, the Complete linkage yields the fewest
singletons and the most balanced distribution of points
among clusters (Sybyl 8.0, Tripos, Inc.). Because clusters
based on the Complete linkage method are comprised of only
similar components, this represents a signiﬁcant advantage
over the other three linkage methods. Thus, we presented
resultsfromtheComplete linkagemethodonly(otherlinkage
methods were attempted but no major diﬀerence in overall
pattern of clustering was found; data not shown). The full
details of algorithms can be found in the software manual
(Sybyl 8.0, Tripos, Inc.).
3. Results andDiscussion
The dendrogram results are displayed in Figures 2 and
3 of aliphatics and aromatics, respectively. The fraction
assignment developed by MADEP is in the ﬁrst column of
Table 1 and is also indicated in the rightmost column in
Figures 2 and 3. The clusters are labeled by numbers in
Figures 2 and 3. Based on intrinsic chemical structures (e.g.,
cyclic versus single chain, and branched versus unbranched
hydrocarbons) and the ﬁnal hierarchical clustering, seven
clusters were manually assigned for the aliphatic fractions
(aliph1–3; numbers 1–7 in Figure 2) based on the separation
of clusters and degree of branching, and six clusters were
manually assigned for the aromatic fractions (arom1–3;
numbers1–6inFigure 3).Consistencyofthefractionassign-
ments for the TPHs was assessed based on the assignment of
the global clusters.
3.1. Clustering Results of Aliphatic TPHs. For the aliphatic
group containing 51 component chemicals, it is apparent
that alkenes (Cluster number 7) are strongly separate and
are most dissimilar to the rest of TPHs that are mostly
straight and branched alkanes (Figure 2). If considering all
alkenes as a global cluster on its own, the rest of dendrogram
can be grouped into six clusters based on the comparable
length of horizontal lines (i.e., CoMFA similarity) as labeled
in Figure 2. Based on this classiﬁcation or grouping, we
compared membership of each TPH component within
Table 2: Consistency of fraction assignment.
Hydrocarbon fraction Consistency Percent consistency
Aliphatic
No.1: C5–C8 25/29 86.2%
No.2: C9–C18 10/16 62.5%
No.3: C19–C32 16/16 100%
Total 41/51 80.4%
Aromatic
No.1: C6–C8 5/6 83.3%
No.2: C9–C18 24/30 66.7%
No.3: C19–C32 24/24 100%
Total 53/60 88.3%
each cluster to its actual fraction assignment by MADEP as
indicatedinthealiphaticfractioncolumn.Ingeneral,Cluster
number 1 represents aliph3, Cluster number 2 represents
aliph2, and the remaining clusters represent aliph1. Consis-
tency of fraction assignment is summarized in Table 2.T h e
overall consistency with the MADEP fraction assignment is
the highest (100%) for aliph3, followed by aliph1 (86.2%)
and aliph2 (62.5%). The overall consistency for the three
aliphatic fractions is 80.4%. The aliphatic dendrogram
suggests that some TPHs assigned by MADEP to aliph2 may
be more similar to compounds in aliph1 based on their 2D
and 3D physicochemical properties. To determine whether
this hypothesis is valid, further hierarchical analysis based
on both toxicity values and CoMFA will be necessary. This
hierarchicalclusteringisheuristicinthesensethatitdepends
on physiochemical properties (CoMFA) only. Future work
may include a 2-way hierarchical clustering using both
CoMFA and a common toxicity endpoint and data which
could facilitate direct comparison of underlying toxicity and
furtherevaluationoftheproposedsurrogatechemicalwithin
each fraction.
3.2. Clustering Results of Aromatic TPHs. For the aromatic
group containing 60 component chemicals, six clusters can
be identiﬁed based on the leftmost level (Figure 3). Clusters
n u m b e r s3 – 6c a nb ec o n s i d e r e da sag l o b a lc l u s t e rb a s e d
on the comparable length of horizontal lines (Figure 3).
This global cluster consists of arom1 and arom2 TPHs only.
Cluster number 1 is the furthest separated from the rest of
the clusters, but it is closer to Cluster number 2. Clusters
numbers 1 and 2 can be considered as another global cluster,
which consists of all arom3 TPHs.
The percent consistency is the highest for arom3 (100%),
followed by arom1 (83.3%), and arom2 (66.7%). The overall
consistency for the three aromatic fractions is 88.3%. The
low consistency percentage within the arom2 fraction can be
explained by two noticeable discrepancies for some TPHs as
follows. (1) Three TPHs (pyrene, anthracene, and biphenyl)
were shown to be strongly clustered with the arom3 fraction
Clusters numbers 1 and 2 instead of arom2 Clusters numbers
3, 4, and 6 (Figure 3) ,a n d( 2 )s e v e nT P H sw i t hl o w e rE C
indices within the arom2 fraction clustered closely with the
arom1TPHs(e.g.,n-propylbenzene).BasedontheclusteringJournal of Toxicology 7
results, we would recommend further analyses for pyrene,
anthracene, and biphenyl for this mixtures risk assessment
approach, as they may be considered as part of arom3 rather
than arom2. As for the low EC TPHs within the arom2
fraction (e.g., n-propylbenzne, isopropylbenzene, etc.), there
issomesuggestiveevidencethatthecutoﬀforthearom2may
be changed to EC11 instead of EC9 by including straight
and branched propylbenzene and butylbenzene in certain
circumstances. This is based on available oral toxicity values
for ethylbenzene (EC8.5) and isopropylbenzene (EC9.13),
as both have similar lowest-observed-adverse-eﬀect levels
(LOAELs) of 291 and 331mg/kg-day, no-observed-adverse-
eﬀect levels (NOAELs) of 97.1 and 110mg/kg-day, respec-
t i v e l y ,a sw e l la si d e n t i c a lR f D so f0 . 1 m g / k g - d a y .F u r t h e r
details can be found in the U.S. Environmental Protection
Agency’s Integrated Risk Information System database [1].
A recent two-generation reproductive study with repeated
exposure to n-butylbenzene suggests that a LOAEL may be
identiﬁed at 300mg/kg-day based on hepatotoxicity (e.g.,
increase liver weight and associated hepatocellular hypertro-
phy; [18]), which is close to the LOAEL for ethylbenzene
based on similar liver toxicity endpoints. Additional toxicity
testing and/or risk assessment for the low EC TPHs will be
needed to support the deviation from the criteria for the
arom2 fraction for these speciﬁc TPHs.
As for components that are not typically considered as
surrogate chemicals for a speciﬁc fraction, components with
diﬀerent and more potent toxicities such as naphthalene
and other substituted naphthalenesin arom2fraction should
be assessed separately based on the recommendation of
MADEP. We found that all naphthalenes clustered closely
(Cluster number 4 in Figure 3), and our results supports the
MADEP recommendation. The only inconsistently classiﬁed
arom1 TPH was m-xylene, as it is shown to cluster closely
with branched alkylbenzenes (Cluster number 6 in Figure 3).
It is uncertain why m-xylene did not cluster with either p
or o-xylene. We tentatively hypothesize that there may be
diﬀerent metabolizing enzymes that are position-speciﬁc,
because the overall shape and volume of m-xylene are
signiﬁcantly diﬀerent from that of p-a n do-xylenes.
3.3. Comparison of Fraction Assignments. In general, the
assignment of membership in a fraction using our integrated
CoMFA/hierarchicalclusteringapproachwasconsistentwith
the MADEP assignments based on analytical chemistry for
environmental fate and transport. We found that the rate
of consistency with the MADEP assignments is >80% on
average for the three fractions in the aliphatic and aro-
maticgroups.WebelievethatCoMFA/hierarchicalclustering
approach for assigning components or individual TPHs
to speciﬁc fractions is complementary to the established
fraction-based approach for TPH mixture assessment.
4. Conclusions
The in silico molecular modeling approach presented in
this paper is an important contribution to the assessment
of risks posed by TPH mixtures and represents the ﬁrst
known case study that applies computational tools to aug-
ment a mixtures risk assessment approach. This integrated
CoMFA/hierarchical clustering approach allows systematic
and objective evaluation of TPH fractions and fractional
membership through a repeatable process. The approach
is capable of clustering or grouping members within a
fraction and assigning membership in a fraction (i.e., a local
cluster). This approach can also identify TPHs that belong in
other fractions (i.e., global clusters). Finally, the approach is
transparent and reproducible, reducing inherent uncertainty
in judgments when chemistry and toxicity information is
limited or not available.
We used the approach to independently evaluate mem-
bership assignments in the TPH fractions that were devel-
oped by MADEP. In general, we found the composition of
the MADEP fractions to be consistent with results from
the CoMFA/hierarchical clustering approach. Concordance
between these approaches reduces the uncertainty associated
with applications of this mixtures method. However, we
also observed some discrepancies between our results and
those of MADEP. For instance, MADEP includes the C5–
C8 TPHs in the arom1 fraction, but our analysis suggests
that some C9-C10 TPHs (e.g., n-propylbenzene, isopropyl-
benzene, and n-butylbenzene) in MADEP’s arom2 fraction
have physicochemical and toxicological properties similar to
TPHs in the arom1 fraction, and may therefore be more
appropriately assigned to arom1. The application of our
approach suggests that additional toxicological evaluations
of some “borderline” TPHs may provide useful insight into
their assignment to a speciﬁc fraction.
Overall, our approach has some limitations in dis-
tinguishing one fraction from another (e.g., arom1 from
arom2) and in deﬁning a cutoﬀ in terms of carbon or
EC number. It is also highly dependent on the available
toxicity information, because the clustering results could
change with consideration of compound-speciﬁc toxicity
values. We believe that in the future, development of a
two-way hierarchical clustering (i.e., CoMFA and toxicity
information) would perform better than the CoMFA-based
approach alone using a subset of TPHs within a fraction.
Further studies could include hierarchical clustering using
both CoMFA descriptors and repeated dose toxicity infor-
mation (e.g., NOAELs, LOAELs, reference values, and cancer
slope factors) as an extra level of ﬁltering for the hierarchical
clustering analysis. A reﬁned clustering using both CoMFA
and a common toxicity endpoint would facilitate a direct
comparison of underlying toxicity and potentially validate
the proposed surrogate chemical within each fraction. By
taking the information and knowledge gained from both
the toxicology and chemistry ﬁelds, an empirical approach
is available to deﬁne similarity and ultimately the grouping
for a speciﬁed fraction for future risk assessments of TPH
mixtures.
A signiﬁcant future application of this approach involves
assigning toxicologically unknown TPHs to fractions prior
to analytical chemistry measurements. Without the actual
measurement of EC number or an expert’s judgment, one
cannot assign a TPH to a speciﬁc fraction with conﬁdence.
Using this in silico approach, toxicologically unknown TPHs8 Journal of Toxicology
can be considered with the rest of the toxicologically known
TPHs in all fractions based on CoMFA descriptors, and the
cluster/fraction which it most closely associates with can
be subsequently identiﬁed (i.e., a range of toxicity can be
inferred). Based on clustering, one may assign membership
in an appropriate fraction based on proximity to the sur-
rogate chemical or the overall clustering/grouping of TPHs
in a fraction (i.e., similar components or chemicals within a
fraction tend to cluster together). In addition, toxicity of the
surrogate chemical within the assigned fraction could serve
as the surrogate toxicity for the unknown TPHs. While this
transparent and empirical approach can address uncertainty
for toxicologically unknown TPHs in a mixture, it cannot
predict an actual toxicity value for the TPHs with unknown
toxicity.
Abbreviations
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